Discover All Perspectives.
Get Started
SubscribeLogin
Israel-Hamas Conflict
World Cup
Boxing
Elon Musk
WWE
Social Media
Donald Trump
Baseball
Natural Disasters
Eid
Cristiano Ronaldo
Artificial Intelligence
Soccer
Published • loading... • Updated

Two Drugs Better Than One for Easing Albuminuria in CKD Patients With Diabetes

Summary by MedPage Today
(MedPage Today) -- An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney disease (CKD) and type 2 diabetes...

3 Articles

All
Left
Center
1
Right
MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

Two Drugs Better Than One for Easing Albuminuria in CKD Patients With Diabetes

(MedPage Today) -- An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney disease (CKD) and type 2 diabetes...

·New York, United States
Read Full Article
Pharmacy TimesPharmacy Times

Vadadustat and Darbepoetin Alfa Show Similar Safety, Efficacy in Patients With NDD-CKD and DD-CKD

Vadadustat and darbepoetin alfa show similar safety and efficacy in treating CKD-related anemia, with regional differences impacting cardiovascular risks.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmacy Times broke the news in on Thursday, June 5, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
SearchBlindspotLocal